Only biotechwith 2 Myron'son theleadershipteamNot manycompaniesthis size with2 late stageassetsWe intendto submita BLA in2H 2022We haveenough cashto go wellinto 2023We willhaveexclusivityMino-Lokpotentialmarket>$1BThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Our Halo-Lido trial willhave finalpatient byend of 2022Insidersinvested$26.5mWe will openupinternationalsites forMino-Lok trialWe had aphase 2btrial with100%efficacyI won't diluteshareholdersI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.There are noFDAapproveddrugs to treathemorrhoidsI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeHemorrhoidsis a $2BmarketAn actualiMSCupdateMino-WrapI/ONTAK'spotentialmarket is>$300mMino-Lokis our leadassetI/Ontak isour leadassetMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearOnly biotechwith 2 Myron'son theleadershipteamNot manycompaniesthis size with2 late stageassetsWe intendto submita BLA in2H 2022We haveenough cashto go wellinto 2023We willhaveexclusivityMino-Lokpotentialmarket>$1BThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Our Halo-Lido trial willhave finalpatient byend of 2022Insidersinvested$26.5mWe will openupinternationalsites forMino-Lok trialWe had aphase 2btrial with100%efficacyI won't diluteshareholdersI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.There are noFDAapproveddrugs to treathemorrhoidsI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeHemorrhoidsis a $2BmarketAn actualiMSCupdateMino-WrapI/ONTAK'spotentialmarket is>$300mMino-Lokis our leadassetI/Ontak isour leadassetMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this year

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
G
2
I
3
O
4
O
5
I
6
G
7
O
8
B
9
B
10
B
11
N
12
G
13
N
14
I
15
G
16
I
17
O
18
B
19
N
20
N
21
I
22
G
23
O
24
B
  1. G-Only biotech with 2 Myron's on the leadership team
  2. I-Not many companies this size with 2 late stage assets
  3. O-We intend to submit a BLA in 2H 2022
  4. O-We have enough cash to go well into 2023
  5. I-We will have exclusivity
  6. G-Mino-Lok potential market >$1B
  7. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  8. B-Our Halo-Lido trial will have final patient by end of 2022
  9. B-Insiders invested $26.5m
  10. B-We will open up international sites for Mino-Lok trial
  11. N-We had a phase 2b trial with 100% efficacy
  12. G-I won't dilute shareholders
  13. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  14. I-There are no FDA approved drugs to treat hemorrhoids
  15. G-I'm a shareholder myself
  16. I-I/ONTAK was the best deal I ever made
  17. O-Hemorrhoids is a $2B market
  18. B-An actual iMSC update
  19. N-Mino-Wrap
  20. N-I/ONTAK's potential market is >$300m
  21. I-Mino-Lok is our lead asset
  22. G-I/Ontak is our lead asset
  23. O-Myron Holubiak and I founded a private company in 2013
  24. B-We expect to finish the Mino-Lok trial this year